Carrolee Barlow - 22 Feb 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
22 Feb 2023
Net transactions value
$0
Form type
4
Filing time
24 Feb 2023, 16:12:25 UTC
Previous filing
24 Feb 2022
Next filing
27 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Award $0 +3,882 +41% $0.000000 13,315 22 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Restricted Stock Units Disposed to Issuer $0 -3,882 -100% $0.000000* 0 22 Feb 2023 Common Stock 3,882 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F2 These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023.

Remarks:

Exhibit 24 - Power of Attorney